SG11202012784SA - Ask1 inhibiting agents - Google Patents
Ask1 inhibiting agentsInfo
- Publication number
- SG11202012784SA SG11202012784SA SG11202012784SA SG11202012784SA SG11202012784SA SG 11202012784S A SG11202012784S A SG 11202012784SA SG 11202012784S A SG11202012784S A SG 11202012784SA SG 11202012784S A SG11202012784S A SG 11202012784SA SG 11202012784S A SG11202012784S A SG 11202012784SA
- Authority
- SG
- Singapore
- Prior art keywords
- inhibiting agents
- ask1
- ask1 inhibiting
- agents
- inhibiting
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862690674P | 2018-06-27 | 2018-06-27 | |
| PCT/US2019/039156 WO2020006031A1 (en) | 2018-06-27 | 2019-06-26 | Ask1 inhibiting agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202012784SA true SG11202012784SA (en) | 2021-01-28 |
Family
ID=67254023
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202012784SA SG11202012784SA (en) | 2018-06-27 | 2019-06-26 | Ask1 inhibiting agents |
Country Status (22)
| Country | Link |
|---|---|
| US (2) | US11814362B2 (en) |
| EP (1) | EP3814333A1 (en) |
| JP (1) | JP2021528456A (en) |
| KR (1) | KR20210024532A (en) |
| CN (1) | CN112638896A (en) |
| AR (1) | AR115636A1 (en) |
| AU (1) | AU2019291806A1 (en) |
| BR (1) | BR112020026423A2 (en) |
| CA (1) | CA3104662A1 (en) |
| CL (1) | CL2020003375A1 (en) |
| CO (1) | CO2021000782A2 (en) |
| CR (1) | CR20210049A (en) |
| EA (1) | EA202190034A1 (en) |
| IL (1) | IL279709A (en) |
| JO (1) | JOP20200318A1 (en) |
| MA (1) | MA53009A (en) |
| MX (1) | MX2020013895A (en) |
| PE (1) | PE20211379A1 (en) |
| SG (1) | SG11202012784SA (en) |
| TW (1) | TW202035389A (en) |
| UY (1) | UY38278A (en) |
| WO (1) | WO2020006031A1 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7432532B2 (en) | 2018-06-27 | 2024-02-16 | ブリストル－マイヤーズ スクイブ カンパニー | Substituted naphthyridinone compounds useful as T cell activators |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4938949A (en) | 1988-09-12 | 1990-07-03 | University Of New York | Treatment of damaged bone marrow and dosage units therefor |
| TWI491606B (en) | 2009-07-13 | 2015-07-11 | Gilead Sciences Inc | Apoptosis signal-regulating kinase inhibitors |
| UY35212A (en) * | 2012-12-21 | 2014-06-30 | Gilead Sciences Inc | INHIBITORS OF THE KINASE THAT REGULATES THE SIGNAL OF APOPTOSIS |
| NZ720660A (en) * | 2013-12-20 | 2018-01-26 | Gilead Sciences Inc | Apoptosis signal-regulating kinase inhibitors |
| WO2018151830A1 (en) | 2017-02-17 | 2018-08-23 | Fronthera U.S. Pharmaceuticals Llc | Pyridinyl based apoptosis signal-regulation kinase inhibitors |
-
2019
- 2019-06-26 JP JP2020572645A patent/JP2021528456A/en active Pending
- 2019-06-26 JO JOP/2020/0318A patent/JOP20200318A1/en unknown
- 2019-06-26 CN CN201980042586.9A patent/CN112638896A/en active Pending
- 2019-06-26 MA MA053009A patent/MA53009A/en unknown
- 2019-06-26 EP EP19739494.3A patent/EP3814333A1/en active Pending
- 2019-06-26 EA EA202190034A patent/EA202190034A1/en unknown
- 2019-06-26 MX MX2020013895A patent/MX2020013895A/en unknown
- 2019-06-26 AU AU2019291806A patent/AU2019291806A1/en not_active Abandoned
- 2019-06-26 CR CR20210049A patent/CR20210049A/en unknown
- 2019-06-26 US US17/253,269 patent/US11814362B2/en active Active
- 2019-06-26 SG SG11202012784SA patent/SG11202012784SA/en unknown
- 2019-06-26 WO PCT/US2019/039156 patent/WO2020006031A1/en unknown
- 2019-06-26 UY UY0001038278A patent/UY38278A/en not_active Application Discontinuation
- 2019-06-26 BR BR112020026423-7A patent/BR112020026423A2/en not_active Application Discontinuation
- 2019-06-26 CA CA3104662A patent/CA3104662A1/en not_active Abandoned
- 2019-06-26 PE PE2020002138A patent/PE20211379A1/en unknown
- 2019-06-26 AR ARP190101780A patent/AR115636A1/en unknown
- 2019-06-26 TW TW108122356A patent/TW202035389A/en unknown
- 2019-06-26 KR KR1020217000614A patent/KR20210024532A/en unknown
-
2020
- 2020-12-23 CL CL2020003375A patent/CL2020003375A1/en unknown
- 2020-12-23 IL IL279709A patent/IL279709A/en unknown
-
2021
- 2021-01-25 CO CONC2021/0000782A patent/CO2021000782A2/en unknown
-
2023
- 2023-10-05 US US18/377,125 patent/US20240109867A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CR20210049A (en) | 2021-07-01 |
| US11814362B2 (en) | 2023-11-14 |
| BR112020026423A2 (en) | 2021-03-23 |
| TW202035389A (en) | 2020-10-01 |
| US20210115020A1 (en) | 2021-04-22 |
| PE20211379A1 (en) | 2021-07-27 |
| CL2020003375A1 (en) | 2021-09-03 |
| WO2020006031A8 (en) | 2020-09-24 |
| WO2020006031A1 (en) | 2020-01-02 |
| JOP20200318A1 (en) | 2020-12-10 |
| IL279709A (en) | 2021-03-01 |
| UY38278A (en) | 2020-01-31 |
| CO2021000782A2 (en) | 2021-01-29 |
| MA53009A (en) | 2021-05-05 |
| CA3104662A1 (en) | 2020-01-02 |
| AU2019291806A1 (en) | 2021-01-07 |
| AR115636A1 (en) | 2021-02-10 |
| EP3814333A1 (en) | 2021-05-05 |
| JP2021528456A (en) | 2021-10-21 |
| US20240109867A1 (en) | 2024-04-04 |
| EA202190034A1 (en) | 2021-04-08 |
| CN112638896A (en) | 2021-04-09 |
| KR20210024532A (en) | 2021-03-05 |
| MX2020013895A (en) | 2021-07-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA187856S (en) | Caddy | |
| IL269711A (en) | Ask1 inhibitor compounds and uses thereof | |
| GB201805174D0 (en) | Compounds | |
| GB201810092D0 (en) | Compounds | |
| GB201801355D0 (en) | Compounds | |
| GB201814169D0 (en) | Blockchain autonoumous agents | |
| GB201807924D0 (en) | Compounds | |
| GB201810581D0 (en) | Compounds | |
| IL279620A (en) | Compounds | |
| GB201814151D0 (en) | Compounds | |
| GB201808093D0 (en) | Compounds | |
| GB201809102D0 (en) | Compounds | |
| IL279709A (en) | Ask1 inhibiting agents | |
| GB201817083D0 (en) | Compounds | |
| GB201812382D0 (en) | Compounds | |
| GB201810071D0 (en) | Compounds | |
| GB201803340D0 (en) | Compounds | |
| GB201814167D0 (en) | Compounds | |
| GB201801128D0 (en) | Compounds | |
| GB201801130D0 (en) | Compounds | |
| CA189391S (en) | Padlock | |
| ZA202103578B (en) | Dna-cutting agent | |
| ZA202103582B (en) | Dna-cutting agent | |
| GB201811826D0 (en) | CAERvest 1 | |
| GB201818410D0 (en) | Compounds |